Search results
Showing 826 to 840 of 1422 results for social care
Romiplostim for the treatment of chronic immune thrombocytopenia (TA221)
Evidence-based recommendations on romiplostim (Nplate) for treating chronic immune thrombocytopenia in adults.
role of primary care in supporting young people discharged from children's services:- What are the most effective ways for primary...
Carers:- In what context is it cost effective to increase uptake of flu vaccination among carers?
This key target group can be difficult to identify, and people who provide care may not always identify themselves as carers. The...
Recommendation ID NG74/4 Question Dementia care:- How effective and cost effective is intermediate care including...
Nalmefene for reducing alcohol consumption in people with alcohol dependence (TA325)
Evidence-based recommendations on nalmefene (Selincro) for reducing alcohol consumption in adults with alcohol dependence.
research, see the rationale section on assessment and care by healthcare professionals and social care practitioners. Full...
Early value assessment (EVA) guidance on digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people....
View recommendations for HTE17Show all sections
residential care:- What factors (including service organisation and management, staff composition, training andsupervision, and the...
Cannabidiol with clobazam for treating seizures associated with Dravet syndrome (TA614)
Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Dravet syndrome in people aged 2 years and older.
Dupilumab for treating moderate to severe prurigo nodularis (TA955)
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe prurigo nodularis in adults when systemic treatment is suitable.
Evidence-based recommendations on rituximab (MabThera) with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in adults.
Dimethyl fumarate for treating moderate to severe plaque psoriasis (TA475)
Evidence-based recommendations on dimethyl fumarate (Skilarence) for treating moderate to severe plaque psoriasis in adults.
of medicines and improving patient-reported outcomes, compared with usual care or other intervention in the UK setting? Any explanatory...
Organisation of care:- What is the clinical and cost effectiveness of alternative approaches to organising primary care...
Evidence-based recommendations on blinatumomab (Blincyto) for treating Philadelphia-chromosome-negative precursor B-cell acute lymphoblastic leukaemia in adults.